Pharmaceutical intermediates
Lotilaner Intermediates
3 pharmaceutical intermediates for Lotilaner. Indication: Demodectic Blepharitis.
About Lotilaner
- Originator
- Elanco Tiergesundheit Ag
- Indication
- Demodectic Blepharitis
- Approved Date
- 07/24/2023
- NCE Patent
- 07/24/2028
- DS/DP
- 01/17/2030
Available intermediates
3 intermediates currently listed for Lotilaner. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 2-bromo-3-methyl-5-acetylthiophene | 859199-06-7 | / | / |
| methyl 5-acetyl-3-methylthiophene-2-carboxylate | 2758907-87-6 | / | / |
| 5-acetyl-3-methyl-2-Thiophenecarboxylic acid | 2758907-91-2 | / | / |
Building toward Lotilaner?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →